Early Clinical Outcomes of Intra-Articular Injections of Bone Marrow Aspirate Concentrate for the Treatment of Early Osteoarthritis of the Hip, and Knee: A Cohort Study

The patient’s own bone marrow concentrate was injected into hips and knees with mild osteoarthritis and found this therapy to be safe and improved pain, stiffness and physical function in 62% of patients. In this Level II evidence prospective cohort study, 25 joints that failed conservative care of PT, NSAIDs and pain medications were studied at 6 to 24 months after injections. Bone marrow was harvested from the patient’s own iliac crest. After 8 months, two patients remained unsatisfied and converted to surgical replacement of the hip.

The Takeaway: It is always recommended that conservative care measures are utilized before moving on to more invasive or risky interventions. It is important that your doctor provides education about all the options that are available for your condition, including the potential risks and benefits of each option so that you can make the right choice for you. At IOW, we strive to exhaust the lowest risk and most conservative options before moving on to higher risk interventions such as surgery.

Reference:

Marrow Aspirate Concentrate for the Treatment of Early Osteoarthritis of the Hip, and Knee: A Cohort Study. PM&R. 2018 Dec;10(12):1353-1359.

Book Appointment